Research and application of key technologies in the prevention and treatment of respiratory allergic diseases with the application of acupoint sticking therapy in summer (bronchial asthma)

Phase 1

Not yet recruiting

• Conditions: bronchial asthma

• Registration Number: ITMCTR2100005014
• Lead Sponsor: The First Affiliated Hospital of Zhejiang Chinese Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Those who meet the diagnostic criteria for bronchial asthma and are clearly diagnosed and are in the non-asthmatic acute exacerbation stage, that is, those who have no fever, hemoptysis, or sudden symptoms such as shortness of breath, cough, chest tightness, and respiratory distress.
2. No other immune enhancers, inhaled glucocorticoids and other drugs or short-term inhaled glucocorticoids (less than 1 month per year) are not used during the treatment.
3. In line with TCM syndrome differentiation standard asthma remission period.
4. Those who sign the informed consent form and are willing to follow the research protocol.
5. Aged 18-65 years.

Exclusion Criteria

1. Patients with other diseases that can cause asthma or dyspnea.
2. Pregnant and lactating patients and those who are allergic to the drugs in the prescription of this test.
3. Combined with serious primary diseases such as cardiovascular, liver, kidney and hematopoietic system, mental patients.
4. Those who are not treated according to the regulations, the data are incomplete, and the curative effect cannot be judged.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Attack times;

Secondary Outcome Measures

Name	Time	Method
Total serum IgE;Standard for quality of life;Degree of attack;Clinical efficacy of patients with cough, sputum and asthma symptoms;